menu search

fibrogen (fgen) fails to meet goals in dmd study, stock down 23%

fibrogen (FGEN) falls 22.7% as its late-stage study of pamrevlumab for the treatment of ambulatory pati...

August 30, 2023, 12:46 pm

fibrogen stock plummets as muscular dystrophy drug trial fails

fibrogen Inc (NASDAQ:FGEN) plummeted some 27% lower in Wednesday's early deals after revealing that its...

August 30, 2023, 9:39 am

fibrogen shares fall after failure in late-stage study of duchenne muscular dystrophy treatment

Shares of fibrogen Inc. FGEN, +3.23% fell 23% premarket on Wednesday after the company said its investi...

August 30, 2023, 7:55 am

fibrogen announces topline results from lelantos-2, a phase 3 clinical study of pamrevlumab in ambulatory duchenne muscular dystrophy

– Study did not meet the primary endpoint – – Pamrevlumab was generally safe and well tolerated – SAN FRANCISCO, Aug. 29, 2023 (GLOBE NEWSWIRE...

August 29, 2023, 8:15 pm

Down -46.88% in 4 weeks, here's why fibrogen (fgen) looks ripe for a turnaround

The heavy selling pressure might have exhausted for fibrogen (FGEN) as it is technically in oversold te...

August 16, 2023, 10:59 am

fibrogen, inc. (fgen) q2 2023 earnings call transcript

fibrogen, Inc. (NASDAQ:FGEN ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Company Partic...

August 7, 2023, 10:10 pm

fibrogen (fgen) q2 earnings: taking a look at key metrics versus estimates

The headline numbers for fibrogen (FGEN) give insight into how the company performed in the quarter end...

August 7, 2023, 9:09 pm

fibrogen (fgen) reports q2 loss, tops revenue estimates

fibrogen (FGEN) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate o...

August 7, 2023, 6:54 pm

Down -83.78% in 4 weeks, here's why fibrogen (fgen) looks ripe for a turnaround

The heavy selling pressure might have exhausted for fibrogen (FGEN) as it is technically in oversold te...

July 11, 2023, 11:03 am

Shareholder alert: pomerantz law firm investigates claims on behalf of investors of fibrogen, inc. – fgen

NEW YORK, July 01, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of f...

July 1, 2023, 10:59 pm

Down 80% in 1 day, is there any hope for fibrogen stock?

fibrogen's lead candidate whiffed twice in June. It has a significant chance of reporting more unfavora...

July 1, 2023, 8:46 am

fibrogen (fgen) plunges on failure of late-stage ipf study

fibrogen (FGEN) plummets on yet another pipeline setback. The phase III study, ZEPHYRUS-1, evaluating t...

June 27, 2023, 2:18 pm

fibrogen's unsteady course: assessing fallout from ipf failure and the road ahead

fibrogen stock has dropped significantly after the failure of its Zephyrus I trial for IPF treatment, l...

June 26, 2023, 3:26 pm

Why is fibrogen (fgen) stock down 81% today?

fibrogen (NASDAQ: FGEN ) stock is heading lower on Monday after the company's Phase 3 clinical trial fa...

June 26, 2023, 10:09 am

fibrogen (fgen) pamrevlumab fails dmd study, stock down 8%

fibrogen???s (FGEN) phase III study, evaluating pamrevlumab as a combination therapy in certain DMD pat...

June 8, 2023, 2:08 pm

Biotech stock falls on late-stage study

fibrogen Inc (NASDAQ:FGEN) stock is sliding today, after the biotech company announced disappointing re...

June 7, 2023, 10:29 am

fibrogen shares slide after duchenne muscular dystrophy treatment falls short in trial

Shares of fibrogen Inc. FGEN, -2.50% were down 5.6% premarket on Wednesday after the company announced ...

June 7, 2023, 8:08 am

fibrogen's neuromuscular disorder drug fails in late-stage study

fibrogen Inc said on Wednesday its drug to treat a type of neuromuscular disorder failed to meet the ma...

June 7, 2023, 7:38 am

fibrogen: several pamrevlumab data releases could change scope of biotech

fibrogen, Inc. results from the phase 3 LELANTOS-1 study, using pamrevlumab for the treatment of patien...

June 5, 2023, 3:27 pm

fibrogen, inc. (fgen) q1 2023 earnings call transcript

fibrogen, Inc. (NASDAQ:FGEN ) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participa...

May 8, 2023, 11:14 pm


Search within

Pages Search Results: